InnoCare Pharma (SHA:688428, HKG:9969) received the first half of the 7% stake of Guangzhou InnoCare Pharma Technology, according to a Shanghai bourse filing on Tuesday.
Guangzhou InnoCare completed the changes in its industry and commerce registration after its parent received its 3.5% stake.
InnoCare bought the remaining 7% of Guangzhou InnoCare for 476.3 million yuan in August.
The pharmaceutical company's shares slipped 1% during the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.